Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
the "Machine Learning and Gene Regulation" team led by William Ritchie, specializing in bioinformatics and post-transcriptional regulation. The scientific environment at the IGH — international seminars, journal
-
About the Opportunity Job Summary Cell and Gene Therapy Master’s Programs at Northeastern University seeks a dynamic and knowledgeable Part-Time Lecturer to teach and oversee practical lab sessions
-
The University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 15 days ago
biomarkers for cancer patients therapy prediction. The individual who will fill this position will be expected to design and perform statistical analyses of gene expression and tumor DNA data and will be
-
for this position. Clinical experience in cellular and gene therapy as an APP is highly desired. Excellent communication and interpersonal skills as measured by references and interviews. Demonstrated ability to work
-
of employment. RESUME REQUIRED (for both internal & external applicants): You must attach a complete and accurate resume to be fully considered for this position. Clinical experience in cellular and gene therapy
-
), Faculty of Medicine, University of Southampton (UoS). The group is studying the Preclinical efficacy and safety of ADAM33 oligonucleotides as new disease-modifying asthma therapy in pre-clinical murine and
-
to staff position within a Research Infrastructure? No Offer Description PhD Position for Synthetic Biology-Inspired Therapies A World-Class Research Environment at the Nexus of Biology, Engineering
-
related to staff position within a Research Infrastructure? No Offer Description Postdoc Position for Synthetic Biology-Inspired Therapies A World-Class Research Environment at the Nexus of Biology
-
to teach BIOL 6216 Applied Bioinformatics for the Cell and Gene Therapy Master’s Programs, depending on program needs and enrollment. This course introduces foundational bioinformatics concepts
-
), Faculty of Medicine, University of Southampton (UoS). The group is studying the Preclinical efficacy and safety of ADAM33 oligonucleotides as new disease-modifying asthma therapy in pre-clinical murine and